187 related articles for article (PubMed ID: 29710721)
1. Change of Amyloid-β 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal Pressure Hydrocephalus.
Akiba C; Nakajima M; Miyajima M; Ogino I; Motoi Y; Kawamura K; Adachi S; Kondo A; Sugano H; Tokuda T; Irie K; Arai H
J Alzheimers Dis; 2018; 63(3):989-1002. PubMed ID: 29710721
[TBL] [Abstract][Full Text] [Related]
2. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Linking Functional Connectivity and Clinical Outcome.
Bommarito G; Van De Ville D; Frisoni GB; Garibotto V; Ribaldi F; Stampacchia S; Assal F; Allali G; Griffa A
J Alzheimers Dis; 2021; 83(4):1717-1728. PubMed ID: 34459399
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
Kang K; Ko PW; Jin M; Suk K; Lee HW
J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
[TBL] [Abstract][Full Text] [Related]
7. Toxic Amyloid-β42 Conformer May Accelerate the Onset of Alzheimer's Disease in the Preclinical Stage.
Futamura A; Hieda S; Mori Y; Kasuga K; Sugimoto A; Kasai H; Kuroda T; Yano S; Tsuji M; Ikeuchi T; Irie K; Ono K
J Alzheimers Dis; 2021; 80(2):639-646. PubMed ID: 33579852
[TBL] [Abstract][Full Text] [Related]
8. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid amyloid beta and response of cognition to a tap test in idiopathic normal pressure hydrocephalus: a case-control study.
Kanemoto H; Mori E; Tanaka T; Suehiro T; Yoshiyama K; Suzuki Y; Kakeda K; Wada T; Hosomi K; Kishima H; Kazui H; Hashimoto M; Ikeda M
Int Psychogeriatr; 2023 Sep; 35(9):509-517. PubMed ID: 34399871
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P
J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350
[TBL] [Abstract][Full Text] [Related]
11. Frontal Behavior Syndromes in Idiopathic Normal Pressure Hydrocephalus as a Function of Alzheimer's Disease Biomarker Status.
Niermeyer M; Gaudet C; Malloy P; Piryatinsky I; Salloway S; Klinge P; Lee A
J Int Neuropsychol Soc; 2020 Oct; 26(9):883-893. PubMed ID: 32430087
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
Manniche C; Hejl AM; Hasselbalch SG; Simonsen AH
J Alzheimers Dis; 2019; 68(1):267-279. PubMed ID: 30741681
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias.
Said HM; Kaya D; Yavuz I; Dost FS; Altun ZS; Isik AT
Clin Interv Aging; 2022; 17():467-477. PubMed ID: 35431542
[TBL] [Abstract][Full Text] [Related]
14. Impact of cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus on the amyloid cascade.
Moriya M; Miyajima M; Nakajima M; Ogino I; Arai H
PLoS One; 2015; 10(3):e0119973. PubMed ID: 25821958
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of coexistence of Alzheimer's disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers.
Lim TS; Choi JY; Park SA; Youn YC; Lee HY; Kim BG; Joo IS; Huh K; Moon SY
BMC Neurol; 2014 Apr; 14():66. PubMed ID: 24690253
[TBL] [Abstract][Full Text] [Related]
16. Cerebral blood flow and Alzheimer's disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus.
Azuma S; Kazui H; Kanemoto H; Suzuki Y; Sato S; Suehiro T; Matsumoto T; Yoshiyama K; Kishima H; Shimosegawa E; Tanaka T; Ikeda M
Psychogeriatrics; 2019 Nov; 19(6):527-538. PubMed ID: 30916850
[TBL] [Abstract][Full Text] [Related]
17. Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia.
Tariciotti L; Casadei M; Honig LS; Teich AF; McKhann Ii GM; Tosto G; Mayeux R
J Alzheimers Dis; 2018; 65(4):1417-1425. PubMed ID: 30149454
[TBL] [Abstract][Full Text] [Related]
18. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus.
Kazui H; Kanemoto H; Yoshiyama K; Kishima H; Suzuki Y; Sato S; Suehiro T; Azuma S; Yoshimine T; Tanaka T
J Neurol Sci; 2016 Oct; 369():236-241. PubMed ID: 27653897
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease.
Kapaki EN; Paraskevas GP; Tzerakis NG; Sfagos C; Seretis A; Kararizou E; Vassilopoulos D
Eur J Neurol; 2007 Feb; 14(2):168-73. PubMed ID: 17250725
[TBL] [Abstract][Full Text] [Related]
20. White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.
Kuroda T; Honma M; Mori Y; Futamura A; Sugimoto A; Kasai H; Yano S; Hieda S; Kasuga K; Ikeuchi T; Ono K
J Alzheimers Dis; 2022; 85(2):851-862. PubMed ID: 34864676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
